Sign up to save your podcasts
Or
Share Why Your First Offer Is Never the Best Offer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Why Your First Offer Is Never the Best Offer
Email blasts, cold calls, and decks full of stats stack up for months before most aesthetic practice founders are even ready to sell.
The buyers on the other end of those messages know exactly what they're doing — they're hoping to lock in a deal before anyone runs a competitive process. The question is whether you understand the playbook well enough to recognize one when it lands in your inbox.
In this solo episode, Bill Walker breaks down how private equity actually structures deals for medical aesthetic and longevity practices. He walks through the difference between a joint venture and an asset purchase agreement, then explains how cash at close, rollover equity, promissory notes, and earnouts each play a distinct role in your total deal value.
Bill explains why a $10 million enterprise value rarely lands as $10 million in your bank account, why rolling 30% equity is a long-horizon bet against the S&P 500 rather than a liquid stock position, and why an unlimited earnout is almost always a worse deal than a tangible one tied to a measurable growth target. He also covers the bonuses and incentives that quietly shape your final number — and what a retrade feels like when you went into the deal without representation.
Stay through the end for Bill's read on the quiet shift among private investors toward whole-body, whole-aesthetic platforms, and why founders who go it alone tend to leave more than 30% of their deal value on the table.
Questions answered by this episode:
1. Should I sell my med spa to private equity?
2. How much is my aesthetic practice worth to private equity?
3. How do private equity firms value medical practices?
4. How are private equity deals structured for healthcare practices?
5. What does cash at close mean in a private equity deal?
6. What is rollover equity in a practice sale?
7. What is a typical earnout in a private equity deal?
8. Do I need an M&A advisor to sell my medical practice?
9. What is the difference between a joint venture and an asset purchase agreement?
10. What is a promissory note in a private equity transaction?
HOST
Bill Walker
Founder & CEO, Aesthetic Brokers
Bill Walker is the Founder & CEO of Aesthetic Brokers, where he leads transaction advisory for medical spas, cosmetic dermatology practices, and plastic surgery centers. Prior to founding Aesthetic Brokers, Bill led mergers & acquisitions for a large private equity-backed healthcare services organization, where he helped doctors unlock hundreds of millions of dollars in generational wealth. He is a nationally recognized speaker and thought leader in healthcare M&A.
Bill began his career as a Marine Corps pilot, ultimately serving under two administrations at the Presidential Helicopter Squadron and commanding a squadron in combat.
Follow Bill on Instagram @aestheticbrokers
Connect with Bill on LinkedIn
About Aesthetic Appeal
Aesthetic Appeal is where Aesthetic Brokers brings you the latest insights straight from Southern California. We break down what's happening in the medical aesthetics world—especially when it comes to private equity and transactions with mergers and acquisitions that matter to you as a practice owner.
Learn more about Aesthetic Brokers
Follow Aesthetic Brokers on Instagram @aestheticbrokers
Theme music: Blinding, Cushy
The buyers on the other end of those messages know exactly what they're doing — they're hoping to lock in a deal before anyone runs a competitive process. The question is whether you understand the playbook well enough to recognize one when it lands in your inbox.
In this solo episode, Bill Walker breaks down how private equity actually structures deals for medical aesthetic and longevity practices. He walks through the difference between a joint venture and an asset purchase agreement, then explains how cash at close, rollover equity, promissory notes, and earnouts each play a distinct role in your total deal value.
Bill explains why a $10 million enterprise value rarely lands as $10 million in your bank account, why rolling 30% equity is a long-horizon bet against the S&P 500 rather than a liquid stock position, and why an unlimited earnout is almost always a worse deal than a tangible one tied to a measurable growth target. He also covers the bonuses and incentives that quietly shape your final number — and what a retrade feels like when you went into the deal without representation.
Stay through the end for Bill's read on the quiet shift among private investors toward whole-body, whole-aesthetic platforms, and why founders who go it alone tend to leave more than 30% of their deal value on the table.
Questions answered by this episode:
1. Should I sell my med spa to private equity?
2. How much is my aesthetic practice worth to private equity?
3. How do private equity firms value medical practices?
4. How are private equity deals structured for healthcare practices?
5. What does cash at close mean in a private equity deal?
6. What is rollover equity in a practice sale?
7. What is a typical earnout in a private equity deal?
8. Do I need an M&A advisor to sell my medical practice?
9. What is the difference between a joint venture and an asset purchase agreement?
10. What is a promissory note in a private equity transaction?
HOST
Bill Walker
Founder & CEO, Aesthetic Brokers
Bill Walker is the Founder & CEO of Aesthetic Brokers, where he leads transaction advisory for medical spas, cosmetic dermatology practices, and plastic surgery centers. Prior to founding Aesthetic Brokers, Bill led mergers & acquisitions for a large private equity-backed healthcare services organization, where he helped doctors unlock hundreds of millions of dollars in generational wealth. He is a nationally recognized speaker and thought leader in healthcare M&A.
Bill began his career as a Marine Corps pilot, ultimately serving under two administrations at the Presidential Helicopter Squadron and commanding a squadron in combat.
Follow Bill on Instagram @aestheticbrokers
Connect with Bill on LinkedIn
About Aesthetic Appeal
Aesthetic Appeal is where Aesthetic Brokers brings you the latest insights straight from Southern California. We break down what's happening in the medical aesthetics world—especially when it comes to private equity and transactions with mergers and acquisitions that matter to you as a practice owner.
Learn more about Aesthetic Brokers
Follow Aesthetic Brokers on Instagram @aestheticbrokers
Theme music: Blinding, Cushy
View all episodes
By Aesthetic BrokersEmail blasts, cold calls, and decks full of stats stack up for months before most aesthetic practice founders are even ready to sell.
The buyers on the other end of those messages know exactly what they're doing — they're hoping to lock in a deal before anyone runs a competitive process. The question is whether you understand the playbook well enough to recognize one when it lands in your inbox.
In this solo episode, Bill Walker breaks down how private equity actually structures deals for medical aesthetic and longevity practices. He walks through the difference between a joint venture and an asset purchase agreement, then explains how cash at close, rollover equity, promissory notes, and earnouts each play a distinct role in your total deal value.
Bill explains why a $10 million enterprise value rarely lands as $10 million in your bank account, why rolling 30% equity is a long-horizon bet against the S&P 500 rather than a liquid stock position, and why an unlimited earnout is almost always a worse deal than a tangible one tied to a measurable growth target. He also covers the bonuses and incentives that quietly shape your final number — and what a retrade feels like when you went into the deal without representation.
Stay through the end for Bill's read on the quiet shift among private investors toward whole-body, whole-aesthetic platforms, and why founders who go it alone tend to leave more than 30% of their deal value on the table.
Questions answered by this episode:
1. Should I sell my med spa to private equity?
2. How much is my aesthetic practice worth to private equity?
3. How do private equity firms value medical practices?
4. How are private equity deals structured for healthcare practices?
5. What does cash at close mean in a private equity deal?
6. What is rollover equity in a practice sale?
7. What is a typical earnout in a private equity deal?
8. Do I need an M&A advisor to sell my medical practice?
9. What is the difference between a joint venture and an asset purchase agreement?
10. What is a promissory note in a private equity transaction?
HOST
Bill Walker
Founder & CEO, Aesthetic Brokers
Bill Walker is the Founder & CEO of Aesthetic Brokers, where he leads transaction advisory for medical spas, cosmetic dermatology practices, and plastic surgery centers. Prior to founding Aesthetic Brokers, Bill led mergers & acquisitions for a large private equity-backed healthcare services organization, where he helped doctors unlock hundreds of millions of dollars in generational wealth. He is a nationally recognized speaker and thought leader in healthcare M&A.
Bill began his career as a Marine Corps pilot, ultimately serving under two administrations at the Presidential Helicopter Squadron and commanding a squadron in combat.
Follow Bill on Instagram @aestheticbrokers
Connect with Bill on LinkedIn
About Aesthetic Appeal
Aesthetic Appeal is where Aesthetic Brokers brings you the latest insights straight from Southern California. We break down what's happening in the medical aesthetics world—especially when it comes to private equity and transactions with mergers and acquisitions that matter to you as a practice owner.
Learn more about Aesthetic Brokers
Follow Aesthetic Brokers on Instagram @aestheticbrokers
Theme music: Blinding, Cushy
The buyers on the other end of those messages know exactly what they're doing — they're hoping to lock in a deal before anyone runs a competitive process. The question is whether you understand the playbook well enough to recognize one when it lands in your inbox.
In this solo episode, Bill Walker breaks down how private equity actually structures deals for medical aesthetic and longevity practices. He walks through the difference between a joint venture and an asset purchase agreement, then explains how cash at close, rollover equity, promissory notes, and earnouts each play a distinct role in your total deal value.
Bill explains why a $10 million enterprise value rarely lands as $10 million in your bank account, why rolling 30% equity is a long-horizon bet against the S&P 500 rather than a liquid stock position, and why an unlimited earnout is almost always a worse deal than a tangible one tied to a measurable growth target. He also covers the bonuses and incentives that quietly shape your final number — and what a retrade feels like when you went into the deal without representation.
Stay through the end for Bill's read on the quiet shift among private investors toward whole-body, whole-aesthetic platforms, and why founders who go it alone tend to leave more than 30% of their deal value on the table.
Questions answered by this episode:
1. Should I sell my med spa to private equity?
2. How much is my aesthetic practice worth to private equity?
3. How do private equity firms value medical practices?
4. How are private equity deals structured for healthcare practices?
5. What does cash at close mean in a private equity deal?
6. What is rollover equity in a practice sale?
7. What is a typical earnout in a private equity deal?
8. Do I need an M&A advisor to sell my medical practice?
9. What is the difference between a joint venture and an asset purchase agreement?
10. What is a promissory note in a private equity transaction?
HOST
Bill Walker
Founder & CEO, Aesthetic Brokers
Bill Walker is the Founder & CEO of Aesthetic Brokers, where he leads transaction advisory for medical spas, cosmetic dermatology practices, and plastic surgery centers. Prior to founding Aesthetic Brokers, Bill led mergers & acquisitions for a large private equity-backed healthcare services organization, where he helped doctors unlock hundreds of millions of dollars in generational wealth. He is a nationally recognized speaker and thought leader in healthcare M&A.
Bill began his career as a Marine Corps pilot, ultimately serving under two administrations at the Presidential Helicopter Squadron and commanding a squadron in combat.
Follow Bill on Instagram @aestheticbrokers
Connect with Bill on LinkedIn
About Aesthetic Appeal
Aesthetic Appeal is where Aesthetic Brokers brings you the latest insights straight from Southern California. We break down what's happening in the medical aesthetics world—especially when it comes to private equity and transactions with mergers and acquisitions that matter to you as a practice owner.
Learn more about Aesthetic Brokers
Follow Aesthetic Brokers on Instagram @aestheticbrokers
Theme music: Blinding, Cushy